Entering a new GALAXI: The importance of long-term data in Crohn’s disease clinical trials
Abstract
Lay Summary Crohn’s disease is a chronic, lifelong condition, but there has been a notable absence of long-term data from clinical trials, with outcomes typically focused on shorter-term outcomes at 6 months, at 1 year, or at most 2 years. The growing amount of longer-term data from clinical trial programs is therefore welcome and valuable for patients to help guide on selection of appropriate therapies and treatment strategies.
Fields of Study & Subjects
Inflammatory Bowel Disease
Biosimilars and Bioanalytical Methods
Celiac Disease Research and Management
Publication details
- Journal / source
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Volume
- 32
- Issue
- 7
- Pages
- 1423–1425
- Publication date
- 2 April 2026
- Language
- EN